Choosing drugs for secondary prevention after myocardial infarction: a pragmatic approach.
作者信息
Channer K S
出版信息
Postgrad Med J. 1995 Jun;71(836):321-2. doi: 10.1136/pgmj.71.836.321.
Abstract
摘要
相似文献
1
Choosing drugs for secondary prevention after myocardial infarction: a pragmatic approach.
Postgrad Med J. 1995 Jun;71(836):321-2. doi: 10.1136/pgmj.71.836.321.
2
Secondary prevention of myocardial infarction: beneficial effect of combining oral anticoagulant plus aspirin: therapy based on evidence.
Clin Appl Thromb Hemost. 2000 Jul;6(3):126-34. doi: 10.1177/107602960000600302.
3
[Platelet antiaggregants or anticoagulants in the secondary prevention after myocardial infarct].
Recenti Prog Med. 1998 Oct;89(10):514-9.
4
Economics and efficacy in choosing oral anticoagulants or aspirin after myocardial infarction.
JAMA. 1995;273(12):965-7.
5
[Anticoagulants or thrombocyte aggregation inhibitors in the prevention of recurrent heart infarction?].
MMW Munch Med Wochenschr. 1983 Apr 8;125(14):285-8.
6
Warfarin, aspirin, or both after myocardial infarction.
N Engl J Med. 2003 Jan 16;348(3):256-7; author reply 256-7. doi: 10.1056/NEJM200301163480315.
7
[Drug therapy as secondary prevention following myocardial infarction].
Praxis (Bern 1994). 1996 Apr 23;85(17):545-7.
8
Warfarin, aspirin, or both after myocardial infarction.
N Engl J Med. 2003 Jan 16;348(3):256-7; author reply 256-7.
9
[Interference in platelet-fibrinogen system for prevention and therapy of myocardial infarct].
Dtsch Med Wochenschr. 1982 Jan 15;107(2):66-70. doi: 10.1055/s-2008-1069874.
10
Secondary prevention in myocardial infarction survivors.
Circulation. 1982 Jan;65(1):216A-219A.
引用本文的文献
1
The one-stop coronary cholesterol clinic: a multidisciplinary approach to implementing evidence-based treatment.
Postgrad Med J. 1996 Dec;72(854):744-8. doi: 10.1136/pgmj.72.854.744.
2
Changes in haemodynamic parameters following Tai Chi Chuan and aerobic exercise in patients recovering from acute myocardial infarction.
Postgrad Med J. 1996 Jun;72(848):349-51. doi: 10.1136/pgmj.72.848.349.
本文引用的文献
1
Treatment of severe heart failure: quantity or quality of life? A trial of enoximone. Enoximone Investigators.
Br Heart J. 1994 Sep;72(3):226-30. doi: 10.1136/hrt.72.3.226.
2
Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trial.
Lancet. 1981 Oct 17;2(8251):823-7. doi: 10.1016/s0140-6736(81)91101-6.
3
Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction.
N Engl J Med. 1988 Jul 14;319(2):80-6. doi: 10.1056/NEJM198807143190204.
4
Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET).
Lancet. 1988 Sep 3;2(8610):525-30. doi: 10.1016/s0140-6736(88)92656-6.
5
Treatment of patients with symptomless left ventricular dysfunction after myocardial infarction.
Lancet. 1988 Feb 6;1(8580):255-9. doi: 10.1016/s0140-6736(88)90347-9.
6
Cumulative meta-analysis of therapeutic trials for myocardial infarction.
N Engl J Med. 1992 Jul 23;327(4):248-54. doi: 10.1056/NEJM199207233270406.
7
Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.
N Engl J Med. 1992 Sep 3;327(10):669-77. doi: 10.1056/NEJM199209033271001.
Zotero 插件